glp-1/gip dual agonist mechanism of action Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research The Premise of the Paradox:

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

A Breakthrough Award, New Evidence in Parkinson's and Heart Disease

Origin: USA

Probiotic supplements work best as part of a comprehensive health strategy that includes balanced nutrition, regular physical activity, quality sleep, and appropriate medical care

Learn how employers can manage GLP-1 costs with strategies that balance affordability and access.

Ascletis ASC35, a once-monthly GLP-1/GIP peptide using a self-assembling lipid depot, cleared FDA IND for Phase 1 head-to-head vs weekly tirzepatide June 23.